Antibe Therapeutics Inc. (ATBPF)
USD 0.22
(0.0%)
USD 0.22
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 40 Thousand CAD | 11.11% |
| 2022 | 36 Thousand CAD | -98.33% |
| 2021 | 2.15 Million CAD | -37.0% |
| 2020 | 3.42 Million CAD | 22.15% |
| 2019 | 2.8 Million CAD | -9.76% |
| 2018 | 3.1 Million CAD | 12.83% |
| 2017 | 2.75 Million CAD | 15.98% |
| 2016 | 2.37 Million CAD | 13162.3% |
| 2015 | 17.89 Thousand CAD | 103.4% |
| 2014 | -526.45 Thousand CAD | -142.93% |
| 2013 | -216.7 Thousand CAD | 0.0% |
| 2012 | - CAD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 44 Thousand CAD | 10.0% |
| 2024 Q3 | 1382.00 CAD | -100.0% |
| 2024 Q2 | 44 Thousand CAD | 0.0% |
| 2023 Q2 | 38 Thousand CAD | 0.0% |
| 2023 Q3 | 913 Thousand CAD | 2302.63% |
| 2023 FY | 40 Thousand CAD | 11.11% |
| 2023 Q4 | 40 Thousand CAD | -95.62% |
| 2023 Q1 | 38 Thousand CAD | -93.32% |
| 2022 Q4 | 569 Thousand CAD | 1624.24% |
| 2022 Q3 | 33 Thousand CAD | 0.0% |
| 2022 FY | 36 Thousand CAD | -98.33% |
| 2022 Q2 | - CAD | -100.0% |
| 2022 Q1 | 2.39 Million CAD | 10.89% |
| 2021 Q2 | 2.58 Million CAD | -22.81% |
| 2021 Q4 | 2.15 Million CAD | -1.64% |
| 2021 FY | 2.15 Million CAD | -37.0% |
| 2021 Q1 | 3.35 Million CAD | -2.04% |
| 2021 Q3 | 2.19 Million CAD | -15.3% |
| 2020 Q1 | 2.93 Million CAD | 4.6% |
| 2020 FY | 3.42 Million CAD | 22.15% |
| 2020 Q4 | 3.42 Million CAD | 7.67% |
| 2020 Q3 | 3.18 Million CAD | -2.45% |
| 2020 Q2 | 3.26 Million CAD | 11.19% |
| 2019 Q4 | 2.8 Million CAD | -5.5% |
| 2019 Q1 | 3.14 Million CAD | 1.16% |
| 2019 Q3 | 2.96 Million CAD | 2.47% |
| 2019 FY | 2.8 Million CAD | -9.76% |
| 2019 Q2 | 2.89 Million CAD | -7.88% |
| 2018 Q3 | 2.67 Million CAD | -8.68% |
| 2018 FY | 3.1 Million CAD | 12.83% |
| 2018 Q2 | 2.92 Million CAD | 1.01% |
| 2018 Q4 | 3.1 Million CAD | 16.12% |
| 2018 Q1 | 2.9 Million CAD | 5.35% |
| 2017 FY | 2.75 Million CAD | 15.98% |
| 2017 Q3 | 2.71 Million CAD | 3.26% |
| 2017 Q4 | 2.75 Million CAD | 1.47% |
| 2017 Q1 | 2.67 Million CAD | 12.85% |
| 2017 Q2 | 2.62 Million CAD | -1.91% |
| 2016 Q3 | 2.54 Million CAD | 5895.72% |
| 2016 Q4 | 2.37 Million CAD | -6.86% |
| 2016 Q2 | 42.5 Thousand CAD | 53.39% |
| 2016 Q1 | 27.71 Thousand CAD | 54.83% |
| 2016 FY | 2.37 Million CAD | 13162.3% |
| 2015 FY | 17.89 Thousand CAD | 103.4% |
| 2015 Q3 | -248.38 Thousand CAD | 10.27% |
| 2015 Q2 | -276.8 Thousand CAD | -110.39% |
| 2015 Q1 | -131.56 Thousand CAD | 75.01% |
| 2015 Q4 | 17.89 Thousand CAD | 107.21% |
| 2014 Q2 | 21.64 Thousand CAD | -69.07% |
| 2014 Q4 | -526.45 Thousand CAD | -503.43% |
| 2014 Q3 | 130.49 Thousand CAD | 503.02% |
| 2014 FY | -526.45 Thousand CAD | -142.93% |
| 2014 Q1 | 69.96 Thousand CAD | 132.28% |
| 2013 FY | -216.7 Thousand CAD | 0.0% |
| 2013 Q4 | -216.7 Thousand CAD | 0.0% |
| 2012 FY | - CAD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| AVITA Medical, Inc. | 3.12 Million USD | 98.719% |
| Manhattan Scientifics, Inc. | - USD | -Infinity% |
| Össur hf. | 136.22 Million USD | 99.971% |
| QHSLab, Inc. | 25.18 Thousand USD | -58.85% |
| Wellstar International, Inc. | - USD | -Infinity% |
| Össur hf. | 136.22 Million USD | 99.971% |
| CVR Medical Corp. | - USD | -Infinity% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| Escalon Medical Corp. | 1.61 Million USD | 97.52% |
| Aurora Spine Corporation | 3.54 Million USD | 98.871% |
| BrainsWay Ltd. | 3.71 Million USD | 98.924% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| BioElectronics Corporation | 41.05 Thousand USD | 2.563% |
| Hamilton Thorne Ltd. | 14.36 Million USD | 99.722% |
| Vivos Inc. | - USD | -Infinity% |
| Kelyniam Global, Inc. | 46.22 Thousand USD | 13.47% |
| REMSleep Holdings, Inc. | 99.14 Thousand USD | 59.656% |
| Zecotek Photonics Inc. | 94.9 Thousand USD | 57.85% |
| Avitar, Inc. | 225.15 Thousand USD | 82.235% |
| Nanomix Corporation | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 11.15 Million USD | 99.642% |
| Theraclion SA | 3.05 Million EUR | 98.691% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Positron Corporation | 1.25 Million USD | 96.817% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 68.51 Thousand USD | 41.62% |
| Lombard Medical, Inc. | 6.87 Million USD | 99.418% |
| ALR Technologies Inc. | - USD | -Infinity% |
| Stratec SE | 157.55 Million USD | 99.975% |
| Vycor Medical, Inc. | 234.14 Thousand USD | 82.917% |
| Heart Tronics, Inc. | 163.85 Thousand USD | 75.588% |
| MicroPort Scientific Corporation | 414.75 Million USD | 99.99% |
| VMS Rehab Systems, Inc. | 1.33 USD | -3007418.797% |
| NewCardio, Inc. | - USD | -Infinity% |
| Guided Therapeutics, Inc. | 632 Thousand USD | 93.671% |
| Ingen Technologies, Inc. | 85.59 Thousand USD | 53.268% |
| Odyssey Group International, Inc. | - USD | -Infinity% |
| CYduct Diagnostics, Inc. | 12.19 Thousand USD | -228.138% |
| Wellness Center USA, Inc. | 125.67 Thousand USD | 68.173% |
| SANUWAVE Health, Inc. | 2.95 Million USD | 98.645% |
| IR-Med Inc. | -81.00 USD | 49482.716% |
| Perimeter Medical Imaging AI, Inc. | 128.99 Thousand USD | 68.992% |
| Polarean Imaging plc | 2.21 Million USD | 98.197% |
| United American Healthcare Corporation | - USD | -Infinity% |
| ECGI Holdings, Inc. | - USD | -Infinity% |
| Nu-Med Plus, Inc. | - USD | -Infinity% |
| Capital Group Holdings, Inc. | - USD | -Infinity% |
| ADM Tronics Unlimited, Inc. | 313.4 Thousand USD | 87.237% |
| Medical Supply International USA, Inc. | 29.3 Thousand USD | -36.495% |
| Urologix, Inc. | 1.39 Million USD | 97.137% |
| Rapid Therapeutic Science Laboratories, Inc. | 175.04 Thousand USD | 77.149% |
| Nexeon MedSystems Inc. | 2.2 Million USD | 98.187% |
| SS Innovations International, Inc. | 6.32 Million USD | 99.368% |
| Qualis Innovations, Inc. | - USD | -Infinity% |
| Smith & Nephew plc | 2.39 Billion USD | 99.998% |
| NIOX Group Plc | 6.11 Million USD | 99.345% |
| Fuse Medical, Inc. | 9.11 Million USD | 99.561% |
| Broncus Holding Corporation | 4.7 Million USD | 99.15% |
| Brain Scientific Inc. | 149.55 Thousand USD | 73.255% |
| Pressure BioSciences, Inc. | 304.9 Thousand USD | 86.881% |
| Health Logic Interactive Inc. | -4511.80 USD | 986.564% |